Advisory Board

Laurent Attias

Senior Vice President, Head of Strategy, BD&L and Market Access, Alcon, USA

Leonard Borrmann

Head of External Innovation, Johnson & Johnson Surgical Vision, Inc., USA

Malvina Eydelman

Director of the office of Ophthalmic, Anesthesia, Respiratory, Ent and dental devices – United States Food and Drug Administration, USA

Michael Giaquinto

Senior Managing Director, SVB Leerink, USA

Rafiq Hasan

Global Head, Ophthalmology, Bayer AG, Germany

Chuck Hess

Vice President & General Manager, US Surgical, Bausch+Lomb, USA

Eugene de Juan

Founder & Managing Partner, ForSight Labs, Menlo Park, USA

Greg Kunst

Vice President, Global Marketing, Glaukos Inc., San Clemente, USA

Akira Kurokawa

Chief Executive Officer and President, Santen Pharmaceutical Co. Ltd., Osaka, Japan

James V. Mazzo

Global President Ophthalmic Devices, Carl Zeiss Meditec, USA

Michael J. O’Rourke

Chief Executive Officer, Re-Vana Therapeutics, Inc., Belfast, UK

Ram Palanki

Senior Vice President, Commercial Strategy & Operations, REGENXBIO, Inc., USA

Dirk Sauer

Global Development Unit Head Ophthalmology, Novartis, Basel, Switzerland

Brent Saunders

Chief Executive Officer and President, Allergan Inc., Dublin, Ireland

Baldo Scasselati Sforzolini

Senior Vice President, Drug Development Operations and Evidence & Value, Allergan Inc., Dublin, Ireland

Naveed Shams

Chief Scientific Officer and Executive Fellow, Santen Pharmaceutical Co. Ltd., Osaka, Japan

Naveed Siddiqi

Partner, Novo Ventures, Novo Holdings A/S, Hellerup, Denmark

Ramin Valian

Vice President, Interventional Glaucoma, Reimbursement and Pipeline-US, Allergan, Inc., USA